Department of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin, USA.
Glia. 2022 Sep;70(9):1777-1794. doi: 10.1002/glia.24219. Epub 2022 May 19.
Norepinephrine exerts powerful influences on the metabolic, neuroprotective and immunoregulatory functions of astrocytes. Until recently, all effects of norepinephrine were believed to be mediated by receptors localized exclusively to the plasma membrane. However, recent studies in cardiomyocytes have identified adrenergic receptors localized to intracellular membranes, including Golgi and inner nuclear membranes, and have shown that norepinephrine can access these receptors via transporter-mediated uptake. We recently identified a high-capacity norepinephrine transporter, organic cation transporter 3 (OCT3), densely localized to outer nuclear membranes in astrocytes, suggesting that adrenergic signaling may also occur at the inner nuclear membrane in these cells. Here, we used immunofluorescence and western blot to show that β -adrenergic receptors are localized to astrocyte inner nuclear membranes; that key adrenergic signaling partners are present in astrocyte nuclei; and that OCT3 and other catecholamine transporters are localized to astrocyte plasma and nuclear membranes. To test the functionality of nuclear membrane β -adrenergic receptors, we monitored real-time protein kinase A (PKA) activity in astrocyte nuclei using a fluorescent biosensor. Treatment of astrocytes with norepinephrine induced rapid increases in PKA activity in the nuclear compartment. Pretreatment of astrocytes with inhibitors of catecholamine uptake blocked rapid norepinephrine-induced increases in nuclear PKA activity. These studies, the first to document functional adrenergic receptors at the nuclear membrane in any central nervous system cell, reveal a novel mechanism by which norepinephrine may directly influence nuclear processes. This mechanism may contribute to previously described neuroprotective, metabolic and immunoregulatory actions of norepinephrine.
去甲肾上腺素对星形胶质细胞的代谢、神经保护和免疫调节功能产生强大影响。直到最近,人们还认为去甲肾上腺素的所有作用都是通过专门位于质膜上的受体来介导的。然而,最近在心肌细胞中的研究已经鉴定出位于细胞内膜(包括高尔基和核内膜)上的肾上腺素能受体,并表明去甲肾上腺素可以通过转运体介导的摄取来接近这些受体。我们最近发现一种高容量的去甲肾上腺素转运体,有机阳离子转运体 3(OCT3),在星形胶质细胞中外核膜上高度定位,这表明肾上腺素能信号也可能发生在这些细胞的核内膜上。在这里,我们使用免疫荧光和 Western blot 显示β-肾上腺素能受体位于星形胶质细胞的核内膜上;关键的肾上腺素能信号伙伴存在于星形胶质细胞核中;OCT3 和其他儿茶酚胺转运体位于星形胶质细胞的质膜和核膜上。为了测试核膜β-肾上腺素能受体的功能,我们使用荧光生物传感器监测星形胶质细胞核中实时蛋白激酶 A(PKA)活性。用去甲肾上腺素处理星形胶质细胞会诱导核区 PKA 活性的快速增加。用儿茶酚胺摄取抑制剂预处理星形胶质细胞会阻止快速去甲肾上腺素诱导的核 PKA 活性增加。这些研究首次在任何中枢神经系统细胞的核膜上记录到功能性肾上腺素能受体,揭示了去甲肾上腺素可能直接影响核过程的新机制。这种机制可能有助于解释去甲肾上腺素先前描述的神经保护、代谢和免疫调节作用。